Total Funding
78
66
Total FundingVenture - Series Unknown raised
Growth Score 78 in past quarter
-9 pts
Heat Score 66 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
14424
Aether Bio is a developer of machine learning technology used to re-purpose enzymes in order to create a new compound.
- Jay Zaveri: PresidentPast Role: Social Capital, Partner | Head, Early Stage & Venture
- Pavle Jeremic: Founder & CEO
About the Company
Aether Bio is a developer of machine learning technology used to repurpose enzymes in order to create new compounds. Its technology utilizes machine learning combined with high-throughput robotic laboratories to create an entirely new compound and reinvent the production of previously discovered compounds that enable healthcare institutes to get
the chemicals and materials they need that are cheaper and more sustainable. The company's proprietary hardware allows massively parallelized experimentation, generating datasets orders of magnitude larger than the competition.